200 related articles for article (PubMed ID: 18691272)
1. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.
Schneider HJ; Sievers C; Klotsche J; Böhler S; Pittrow D; Lehnert H; Wittchen HU; Stalla GK
Clin Endocrinol (Oxf); 2009 Mar; 70(3):446-54. PubMed ID: 18691272
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
Mulligan T; Frick MF; Zuraw QC; Stemhagen A; McWhirter C
Int J Clin Pract; 2006 Jul; 60(7):762-9. PubMed ID: 16846397
[TBL] [Abstract][Full Text] [Related]
3. Testosterone levels in men with erectile dysfunction.
Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P
BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
[TBL] [Abstract][Full Text] [Related]
5. Hypogonadism in male patients with cancer.
Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
[TBL] [Abstract][Full Text] [Related]
6. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.
Corona G; Mannucci E; Schulman C; Petrone L; Mansani R; Cilotti A; Balercia G; Chiarini V; Forti G; Maggi M
Eur Urol; 2006 Sep; 50(3):595-604; discussion 604. PubMed ID: 16564129
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of androgen deficiency in men with erectile dysfunction.
Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
9. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology: testosterone and the metabolic syndrome.
Svartberg J
Int J Impot Res; 2007; 19(2):124-8. PubMed ID: 16858366
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
[TBL] [Abstract][Full Text] [Related]
16. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadism and diabetes.
Betancourt-Albrecht M; Cunningham GR
Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
Ogbera OA; Sonny C; Olufemi F; Wale A
J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadotropic hypogonadism in men with type 2 diabetes.
Dandona P; Dhindsa S; Chandel A; Chaudhuri A
Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
